| # | Drug | Count |
|---|---|---|
| 0 | ALTEPLASE | 37 |
| 1 | ASPIRIN | 25 |
| 2 | RIVAROXABAN | 25 |
| 3 | ASPIRIN 325 MG | 24 |
| 4 | ASPIRIN 81 MG | 24 |
| 5 | LISINOPRIL | 21 |
| 6 | FUROSEMIDE | 16 |
| 7 | CLOPIDOGREL | 15 |
| 8 | METOPROLOL | 15 |
| 9 | METOPROLOL TARTRATE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TENECTEPLASE | 10 | 0.0063 |
| 1 | IDARUCIZUMAB | 4 | 0.0028 |
| 2 | ALTEPLASE | 37 | 0.0025 |
| 3 | IOPAMIDOL | 5 | 0.0017 |
| 4 | MENTHOL, UNSPECIFIED FORM | 1 | 0.0016 |
| 5 | SODIUM POLYSTYRENE SULFONATE | 2 | 0.0013 |
| 6 | PROPYLTHIOURACIL | 2 | 0.0010 |
| 7 | GADOBENATE DIMEGLUMINE | 3 | 0.0007 |
| 8 | EDARAVONE | 1 | 0.0006 |
| 9 | PALONOSETRON HYDROCHLORIDE | 3 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 1 | Factor Xa Inhibitor [EPC] | 30 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 3 | beta-Adrenergic Blocker [EPC] | 19 |
| 4 | Corticosteroid [EPC] | 16 |
| 5 | Loop Diuretic [EPC] | 16 |
| 6 | Insulin Analog [EPC] | 13 |
| 7 | alpha-Adrenergic Blocker [EPC] | 13 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 4 | 0.0028 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 3 | Radiographic Contrast Agent [EPC] | 7 | 0.0003 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Potassium Binder [EPC] | 2 | 0.0001 |